研飞ivySCI (青藤学术）

Neoplasia (United States)

短名
Journal Impact	6.15
国际分区	ONCOLOGY(Q1)
期刊索引	SCI Q2中科院 2 区

ISSN	1476-5586, 1522-8002
h-index	144
国内分区	医学(2区)医学肿瘤学(2区)

NEOPLASIA 发表肿瘤学研究所有领域的新研究结果。选择 NEOPLASIA 这个标题是为了传达该期刊的广度，其中包括癌症研究的传统学科以及新兴领域和跨学科研究。瘤形成对描述与肿瘤表型相关的新分子和遗传学发现的研究以及实验室和临床研究感兴趣，这些研究表明基础科学进展在风险评估、预后适应症、检测、诊断和治疗方面的创造性应用。除了定期的研究报告外，NEOPLASIA 还发布评论和会议报告。 NEOPLASIA 致力于确保一个彻底、公平和快速的审查和出版时间表，以通过传播癌症研究中的重要数据和想法来推进其为科学和临床社区服务的使命。

期刊主页投稿网址

涉及主题	生物遗传学医学化学内科学生物化学癌症研究癌症基因细胞生物学病理免疫学细胞凋亡细胞培养分子生物学信号转导受体细胞
出版信息	出版商: Elsevier Inc.，出版周期: Monthly，期刊类型: journal
基本数据	创刊年份: 1999，原创研究文献占比: 93.62%，自引率:1.60%， Gold OA占比: 98.62%
平均审稿周期	网友分享经验：平均1月
平均录用比例	网友分享经验：约15%

期刊引文格式

这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。

专利引用格式

PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation

2024-11-1

Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin

2024-11-1

FABP4 facilitates epithelial-mesenchymal transition via elevating CD36 expression in glioma cells

2024-11-1

Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapy

2024-11-1

The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletions

2024-11-1

Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics

2024-11-1

Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer

2024-11-1

Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells

2024-11-1

Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer

2024-11-1

Corrigendum to “Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL” [Neoplasia. Vol. 9, No. 5, May 2007, pp. 435–442]

2024-10-1

Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [Neoplasia, volume 12, issue 10 (2010):848 –855]

2024-10-1

The advancements and prospective developments in anti-tumor targeted therapy

2024-10-1

Efficacy and safety of pyrotinib-based regimens in HER2 positive metastatic breast cancer: A retrospective real-world data study

2024-10-1

Epitranscriptomic mechanisms of androgen signalling and prostate cancer

2024-10-1

Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada

2024-10-1

Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer

2024-9-13

Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract

2024-9-13

Probing the glioma micro-environment: Analysis using biopsy in combination with ultra-fast cyclic immunolabeling

2024-9-12

ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer

2024-9-11

Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression

2024-9-10

A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colon

2024-9-10

Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study

2024-9-2

PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway

2024-9-2

GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer

2024-9-1

Corrigendum to “SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway” [Neoplasia (2021) 23, 1037–1047]

2024-9-1

GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors

2024-9-1

Glycolysis in gastrointestinal stromal tumor: a brief overview

2024-9-1

Corrigendum to “Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells” [Neoplasia 39 (2023), 100893]

2024-9-1

Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells

2024-9-1

Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]

2024-9-1

LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44

2024-8-10

PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma

2024-8-2

B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas

2024-8-1

WDR68 stimulates cellular proliferation via activating ribosome biogenesis in 293T cells

2024-7-27

A new, simplified endoscopic scoring system for predicting clinical outcome in gastric low-grade intraepithelial neoplasia: the “e-cout system”

2024-7-23

Characterization and integrated analysis of extrachromosomal DNA amplification in hematological malignancies

2024-7-13

Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells

2024-7-1

Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing

2024-7-1

Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]

2024-7-1

Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production

2024-7-1

Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation

2024-7-1

Tumor marker-based RecistTM is superior to RECIST as criteria to predict the long-term benefits of targeted therapy in advanced non-small-cell lung cancer with driver gene mutations

2024-7-1

ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells

2024-6-29

Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary

2024-6-28

Aurkin-A, a TPX2-aurora a small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma

2024-6-14

Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance

2024-6-14

Epstein-Barr virus deubiquitinating enzyme BPLF1 is involved in EBV carcinogenesis by affecting cellular genomic stability

2024-6-13

Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma

2024-6-7

Unveiling the role of AGT in lipid metabolism and regulated cell death in colon cancer

2024-6-7

Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms

2024-6-1

帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理

投稿经验分享

分享我的经验，帮你走得更远

Neoplasia (United States)

期刊引文格式

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

学位论文引用格式

网页引用格式

专利引用格式

最新文章

PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation

Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin

FABP4 facilitates epithelial-mesenchymal transition via elevating CD36 expression in glioma cells

Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapy

The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletions

Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics

Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer

Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells

Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer

Corrigendum to “Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL” [Neoplasia. Vol. 9, No. 5, May 2007, pp. 435–442]

Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [Neoplasia, volume 12, issue 10 (2010):848 –855]

The advancements and prospective developments in anti-tumor targeted therapy

Efficacy and safety of pyrotinib-based regimens in HER2 positive metastatic breast cancer: A retrospective real-world data study

Epitranscriptomic mechanisms of androgen signalling and prostate cancer

Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada

Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer

Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract

Probing the glioma micro-environment: Analysis using biopsy in combination with ultra-fast cyclic immunolabeling

ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer

Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression

A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colon

Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study

PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway

GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer

Corrigendum to “SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway” [Neoplasia (2021) 23, 1037–1047]

GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors

Glycolysis in gastrointestinal stromal tumor: a brief overview

Corrigendum to “Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells” [Neoplasia 39 (2023), 100893]

Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells

Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]

LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44

PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma

B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas

WDR68 stimulates cellular proliferation via activating ribosome biogenesis in 293T cells

A new, simplified endoscopic scoring system for predicting clinical outcome in gastric low-grade intraepithelial neoplasia: the “e-cout system”

Characterization and integrated analysis of extrachromosomal DNA amplification in hematological malignancies

Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells

Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing

Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]

Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production

Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation

Tumor marker-based RecistTM is superior to RECIST as criteria to predict the long-term benefits of targeted therapy in advanced non-small-cell lung cancer with driver gene mutations

ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells

Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary

Aurkin-A, a TPX2-aurora a small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma

Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance

Epstein-Barr virus deubiquitinating enzyme BPLF1 is involved in EBV carcinogenesis by affecting cellular genomic stability

Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma

Unveiling the role of AGT in lipid metabolism and regulated cell death in colon cancer

Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms

帮你贴心管理全部的文献.css-5myebc{font-size:14px;font-weight:var(--chakra-fontWeights-normal);margin-top:var(--chakra-space-1);margin-bottom:var(--chakra-space-1);}研飞ivySCI，高效的论文管理

帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理